Global Imaging Biomarkers Market 2014-2018

March 25, 2014

DUBLIN, March 25, 2014 /PRNewswire/ –

Research and Markets (
http://www.researchandmarkets.com/research/tp3h3r/global_imaging) has announced the
addition of the “Global Imaging Biomarkers Market 2014-2018″
[http://www.researchandmarkets.com/research/tp3h3r/global_imaging ] report to their

http://photos.prnewswire.com/prnh/20130307/600769 )

The analysts forecast the Global Imaging Biomarkers market to grow at a CAGR of 15.09
percent over the period 2013-2018. One of the key factors contributing to this market
growth is the increasing prevalence of cancer. The Global Imaging Biomarkers market has
also been witnessing the emergence of personalized medicines. However, the poor regulatory
and reimbursement systems could pose a challenge to the growth of this market.

The report, the Global Imaging Biomarkers Market 2014-2018, has been prepared based on
an in-depth market analysis with inputs from industry experts. The report covers the
market in the Americas, and the EMEA and APAC regions; it also covers the Global Imaging
Biomarkers market landscape and its growth prospects in the coming years. The report also
includes a discussion of the key vendors operating in this market.

The Global Imaging Biomarkers market has been witnessing an increase in the number of
strategic alliances being formed among organizations. Mergers and acquisitions help
organizations grow rapidly, expand their business processes, and gain more market share.
The introduction of innovative technologies by small and mid-sized companies is prompting
major pharmaceutical and biotechnology companies to form strategic alliances with these
smaller companies to identify various imaging biomarkers.

The increase in strategic alliances is resulting in an increase in the application
base for imaging biomarkers in drug discovery and diagnosis domains. For instance, in
2012, Genomic Health Inc. and OncoMed Pharmaceuticals announced a strategic alliance for
Biomarker Research and Discovery using the Next-generation Sequencing process.

According to the report, the use of imaging biomarkers in the field of drug discovery
has increased considerably over the past few years. The increase in the demand for imaging
biomarkers is primarily because of their ability to be used in target discovery and
validation, identification of disease mechanisms, toxicity profiling, and proof-of-concept

Further, the report states that one of the main challenges hindering the growth of
this market is the presence of poor regulatory and reimbursements systems. The current
regulatory and reimbursement systems present in various countries are not well-suited for
imaging biomarker-based diagnostics. The development of novel and useful imaging
biomarkers is also an expensive and time-consuming process.

The study was conducted using an objective combination of primary and secondary
information including inputs from key participants in the industry. The report contains a
comprehensive market and vendor landscape in addition to a SWOT analysis of the key

Key Topics Covered:

1. Executive Summary

2. List of Abbreviations

3. Scope of the Report

4. Market Research Methodology

5. Introduction

6. Market Landscape

7. Geographical Segmentation

8. Buying Criteria

9. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape

16. Key Vendor Analysis

17. Other Reports in this Series

Companies Mentioned:

        - Abbott Laboratories
        - Agilent Technologies Inc.
        - Affymetrix Inc.
        - Bio-Rad Laboratories Inc.
        - F. Hoffmann La Roche Ltd.
        - Gen-Probe Inc.
        - Siemens Healthcare.

For more information visit


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net



SOURCE Research and Markets

Source: PR Newswire

comments powered by Disqus